Resmed Inc Drc Stock Current Valuation
| RMEA Stock | EUR 20.00 0.20 0.99% |
Valuation analysis of Resmed Inc DRC helps investors to measure Resmed's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Undervalued
Today
Please note that Resmed's price fluctuation is very steady at this time. Calculation of the real value of Resmed Inc DRC is based on 3 months time horizon. Increasing Resmed's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Resmed stock is determined by what a typical buyer is willing to pay for full or partial control of Resmed Inc DRC. Since Resmed is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Resmed Stock. However, Resmed's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 20.0 | Real 20.89 | Hype 20.0 | Naive 19.58 |
The real value of Resmed Stock, also known as its intrinsic value, is the underlying worth of Resmed Inc DRC Company, which is reflected in its stock price. It is based on Resmed's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Resmed's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Resmed Inc DRC helps investors to forecast how Resmed stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Resmed more accurately as focusing exclusively on Resmed's fundamentals will not take into account other important factors: Resmed Inc DRC Company Current Valuation Analysis
Resmed's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Resmed Current Valuation | 31.38 B |
Most of Resmed's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Resmed Inc DRC is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Resmed Inc DRC has a Current Valuation of 31.38 B. This is 118.48% higher than that of the Healthcare sector and 243.22% higher than that of the Medical Instruments & Supplies industry. The current valuation for all Germany stocks is 88.77% lower than that of the firm.
Resmed Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Resmed's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Resmed could also be used in its relative valuation, which is a method of valuing Resmed by comparing valuation metrics of similar companies.Resmed is currently under evaluation in current valuation category among its peers.
Resmed Fundamentals
| Return On Equity | 0.24 | |||
| Return On Asset | 0.12 | |||
| Profit Margin | 0.22 % | |||
| Operating Margin | 0.28 % | |||
| Current Valuation | 31.38 B | |||
| Shares Outstanding | 1.47 B | |||
| Shares Owned By Institutions | 7.92 % | |||
| Price To Earning | 41.55 X | |||
| Price To Book | 9.35 X | |||
| Price To Sales | 8.00 X | |||
| Revenue | 3.58 B | |||
| Gross Profit | 2.06 B | |||
| EBITDA | 1.19 B | |||
| Net Income | 779.44 M | |||
| Cash And Equivalents | 147.13 M | |||
| Cash Per Share | 0.10 X | |||
| Total Debt | 765.33 M | |||
| Debt To Equity | 61.30 % | |||
| Current Ratio | 2.06 X | |||
| Book Value Per Share | 6.36 X | |||
| Cash Flow From Operations | 351.15 M | |||
| Earnings Per Share | 0.51 X | |||
| Price To Earnings To Growth | 1.73 X | |||
| Number Of Employees | 8.16 K | |||
| Beta | 0.47 | |||
| Market Capitalization | 29.64 B | |||
| Total Asset | 5.1 B | |||
| Z Score | 22.8 | |||
| Annual Yield | 0.01 % | |||
| Net Asset | 5.1 B | |||
| Last Dividend Paid | 1.72 |
About Resmed Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Resmed Inc DRC's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Resmed using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Resmed Inc DRC based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Resmed Stock
Resmed financial ratios help investors to determine whether Resmed Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Resmed with respect to the benefits of owning Resmed security.